Free tool
Oncology stocks
We cover 2 companies grouped under the Oncology theme. The median market value in the group is $82.85M. Across the group, the median move over the past trading day is −0.16%. Price change over the past year runs from −73.0% to −31.7% across the middle 80 percent of the group, with a median of −52.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0J4V.L | Heron Therapeutics, Inc. | $82.85M | Micro cap | −78.12% | Nov 3, 2026 |
| 0HS8.L | Lisata Therapeutics, Inc. | — | — | −26.55% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.